Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (MRMD)
OTHER OTC:MRMD
MariMed (MRMD) Stock Price & Analysis
413 Followers
MRMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.16 - $0.55
Previous Close$0.17
Volume263.14K
Average Volume (3M)413.30K
Market Cap
$62.64M
Enterprise Value$127.99M
Total Cash (Recent Filing)$15.23M
Total Debt (Recent Filing)$82.27M
Price to Earnings (P/E)―
Beta0.91
Next Earnings
Aug 07, 2024EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding379,643,844
10 Day Avg. Volume308,504
30 Day Avg. Volume413,300
Standard Deviation0.40
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.72
Price to Sales (P/S)2.01
Price to Cash Flow (P/CF)5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.87
Enterprise Value/Gross Profit1.94
Enterprise Value/Ebitda5.55
Forecast
1Y Price Target
$0.40Price Target Upside135.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
MariMed News
Bulls Say, Bears Say
Bulls Say
Future Growth DriversExpansion through new dispensaries and cultivation facilities, along with the implementation of adult-use sales in Delaware, positions the company for significant growth.
Liquidity PositionImproved liquidity from debt refinancing strengthens the company's financial foundation, enabling it to manage cash burn more effectively.
Wholesale Segment PerformanceThe wholesale segment consistently outperforms forecasts, showing robust gains in revenue.
Bears Say
Cost ManagementCost management remains an area of concern, with costs embedded in COGS causing a drag on gross margins and operating costs increasing by 41%.
EarningsMariMed Inc. reported Q4 results that were below expectations, with sales slightly below consensus estimates and adj. EBITDA well below expectations due to higher operating costs.
LiquidityFurther delays to new cultivation facilities or store openings could continue to result in under-absorption of operating costs, affecting liquidity.
---
Ownership Overview
27.93% Insiders
0.00% Mutual Funds
0.30% Other Institutional Investors
71.76% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
MRMD FAQ
What was MariMed Inc’s price range in the past 12 months?
MariMed Inc lowest stock price was $0.15 and its highest was $0.55 in the past 12 months.
What is MariMed Inc’s market cap?
Currently, no data Available
When is MariMed Inc’s upcoming earnings report date?
MariMed Inc’s upcoming earnings report date is Aug 07, 2024 which is in 19 days.
How were MariMed Inc’s earnings last quarter?
MariMed Inc released its earnings results on May 08, 2024. The company reported $0 earnings per share for the quarter, beating the consensus estimate of -$0.01 by $0.01.
Is MariMed Inc overvalued?
According to Wall Street analysts MariMed Inc’s price is currently Undervalued.
Does MariMed Inc pay dividends?
MariMed Inc does not currently pay dividends.
What is MariMed Inc’s EPS estimate?
MariMed Inc’s EPS estimate is -$0.01.
How many shares outstanding does MariMed Inc have?
MariMed Inc has 379,643,830 shares outstanding.
What happened to MariMed Inc’s price movement after its last earnings report?
MariMed Inc reported an EPS of $0 in its last earnings report, beating expectations of -$0.01. Following the earnings report the stock price went down -3.448%.
Which hedge fund is a major shareholder of MariMed Inc?
Currently, no hedge funds are holding shares in MRMD
---
MariMed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.40 (135.29% Upside)
$0.40 (135.29% Upside)
Blogger Sentiment
Bullish
MRMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.80%
12-Months-Change
Fundamentals
Return on Equity
-19.06%
Trailing 12-Months
Asset Growth
9.19%
Trailing 12-Months
Company Description
MariMed Inc
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. The company develops precision-dosed cannabis-infused products designed for specific medical conditions and related symptoms. Its products are licensed under brands of Kalm Fusion, Betty's Eddies, and Nature's Heritage, in the form of dissolvable strips, tablets, powders, microwaveable popcorn, and fruit chews. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
---
MRMD Earnings Call
Q1 2024
0:00 / 0:00
---
MRMD Stock 12 Month Forecast
Average Price Target
$0.40
▲(135.29% Upside)
Technical Analysis
Best Analysts Covering MRMD
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-35.94%
reiterated a buy rating 2 months ago
Copying Andrew Semple's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -35.94% per trade.
---